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The host immune system offers a hostile environment with antimicrobials
and reactive oxygen species (ROS) that are detrimental to bacterial patho-
gens, forcing them to adapt and evolve for survival. However, the
contribution of oxidative stress to pathogen evolution remains elusive.
Using an experimental evolution strategy, we show that exposure of the
opportunistic pathogen Pseudomonas aeruginosa to sub-lethal hydrogen per-
oxide (H2O2) levels over 120 generations led to the emergence of pro-
biofilm rough small colony variants (RSCVs), which could be abrogated
by L-glutathione antioxidants. Comparative genomic analysis of the RSCVs
revealed that mutations in the wspF gene, which encodes for a repressor of
WspR diguanylate cyclase (DGC), were responsible for increased intra-
cellular cyclic-di-GMP content and production of Psl exopolysaccharide.
Psl provides the first line of defence against ROS and macrophages, ensuring
the survival fitness of RSCVs over wild-type P. aeruginosa. Our study
demonstrated that ROS is an essential driving force for the selection of
pro-biofilm forming pathogenic variants. Understanding the fundamental
mechanism of these genotypic and phenotypic adaptations will improve
treatment strategies for combating chronic infections.1. Background
Bacterial pathogens can colonize human hosts for years and cause persistent/
chronic infections [1,2]. These infections predominantly result from biofilm
formation, whereby secreted extracellular-polymeric substances (EPS) such as
adhesive proteins, biosurfactants, extracellular DNA and exopolysaccharides
act as physical barriers to protect bacterial cells from the host immune clearance
and antimicrobial treatments [3–5].
The transition between free-living planktonic and sessile biofilm lifestyles
of most bacterial species is mediated by bis-(30-50)-cyclic dimeric guanosine
monophosphate (c-di-GMP), a global intracellular secondary messenger [6,7].
Increase in intracellular c-di-GMP content is caused by the activity of
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formation, whereas phosphodiesterases (PDEs) degrade c-
di-GMP [10,11] and cause biofilm dispersal to the planktonic
phase [12,13]. C-di-GMP signalling is involved not only in
motility, surface attachment and production of EPS [14–16],
but also in the sensing of chemicals and surfaces [8].
C-di-GMP signalling also regulates virulence and stress
responses in pathogens [17,18].
Pseudomonas aeruginosa is the leading cause of chronic lung
infection and morbidity of patients with cystic fibrosis (CF)
[19,20]. It is able to survive and form biofilms despite the
presence of a functional host immune system, antibiotic treat-
ments and competing pathogens, such as Staphylococcus
aureus in the CF lung environment [21–24]. Investigations of
adaptive evolution of P. aeruginosa in CF lung infections have
provided valuable information for our current understanding
of chronic infections. P. aeruginosa can colonize the CF lungs
for decades and usually gives rise to pro-biofilm sub-
populations after adaptive evolution [25,26]. The occurrence
of rough small colony variants (RSCVs) and mucoid strains is
often reported from chronic CF infections, implying these
variants have better fitness than their ancestors [27,28].
Although the characteristics of RSCVs have been studied
[29,30], the stimuli and mechanisms leading to the evolution
of such adapted sub-populations are unclear. Given the CF
environment consists of oxidative stress, high antibiotic con-
centrations, high pro-inflammatory cytokine levels and poor
nutrient conditions [31–35], it is highly likely that each of
the CF-derived environmental factors can drive the adaptive
evolution of pathogens differently.
Experimental evolution assays have been used in pre-
vious studies to investigate bacterial adaptation to various
conditions such as antibiotic treatments and carbon sources
[18,36]. Here, we employed the adaptive experimental evol-
ution assay to evolve P. aeruginosa against an important
host-derived antimicrobial, reactive oxygen species (ROS),
resulting in the occurrence of RSCVs with a strong capability
for biofilm formation and ROS stress resistance.
The RSCVs isolated from H2O2 treated cultures showed
increased intracellular c-di-GMP content. Next-generation
sequencing (NGS) analysis revealed that wspF mutation was
associated with these isolated RSCVs. The wspF is part of
the chemosensory-like system Wsp (wrinkly spreader pheno-
type) [8], whose product acts as a repressor against WspR
(DGC), thus its mutagenesis leads to the de-repression of
WspR. The increased production of exopolysaccharides
(especially Psl) as the result of wspF mutation conferred
resistance of RSCVs to H2O2 treatment. Hence, this work
strongly suggests that exposure to ROS imposes a strong
selective pressure on P. aeruginosa during chronic coloniza-
tion and accounts for the occurrence of RSCVs in clinical
isolates obtained from CF patients.2. Material and methods
2.1. Bacterial strains, plasmids, media and growth
conditions
Escherichia coliDH5a strainwas used for standardDNAmanip-
ulations. Luria-Bertani (LB) medium was used to cultivate
E. coli strains. Batch cultivation of P. aeruginosa strains was
carried out at 378C in ABTG (ABT minimal mediumsupplemented with 5 g l21 glucose) or ABTGC (ABT minimal
medium supplemented with 2 g l21 glucose and 2 g l21 cas-
amino acids). For plasmid maintenance in E. coli, the medium
was supplemented with 100 mg ml21 ampicillin (Ap),
15 mg ml21 gentamicin (Gm) and 15 mg ml21 tetracycline (Tc).
When appropriate, the marker selection in P. aeruginosa,
30 mg ml21 Gm, 50 mg ml21 Tc or 200 mg ml21 carbenicillin
(Cb), was used. The bacterial strains and plasmids are listed
in the electronic supplementary material, table S1.
2.2. Imaging colony morphology of Pseudomonas
aeruginosa
Cultures were streaked on LB agar together with 40 mg ml21
Congo Red and 15 mg ml21 Coomassie Brilliant Blue R at
378C for 48 h as previously described [37]. Colony images
were captured by the stereomicroscope (Zeiss Discovery V8,
Germany) and processed using IMARIS software (Bitplane
AG, Zurich, Switzerland).
2.3. Evolution assay of Pseudomonas aeruginosa PAO1
in H2O2 and GSH
Cultures were cultivated overnight from ancestral PAO1 at
378C, 200 rpm in LB with three biological replicates. Each bio-
logical replicate with initially identical populations was then
divided into three technical replicates, each grown in ABTGC
only or ABTGC with 2 mM H2O2 þ 5, 2.5, 1, 0.25, 0.125 or
0 mMGSH.Oneper cent of each replicate populationwas trans-
ferred to a new tube of fresh ABTGC with and without 2 mM
H2O2 þ GSH at 378C, 200 rpm for 12 h, allowing each popu-
lation to experience an estimated 6.67 generations every
passage. This was then repeated for 15 days, so that there
were an estimated 120 generations of cells grown in 2 mMH2O2.
The populations were then cryopreserved with 50% gly-
cerol (cryoprotectant) for revival at a later time. To observe
the emergence of unique phenotypes arising from treatment
with 2 mM H2O2, the populations were grown on LB agar
plates at 378C overnight. Ten RSCV isolates were identified
from the different replicates and frozen with 50% glycerol.
2.4. H2O2 resistance assay
The P. aeruginosa cultures were grown overnight and prepared
by adjusting the optical density to OD600 ¼ 0.3 in ABTGCwith
and without 4 mM H2O2. The cultures were grown at 378C,
200 rpm for 4 h. The cell culture was serially diluted and
plated on LB agar plates. The culture plates were incubated
in 378C for 16 h. The numbers of colonies were counted for
tabulation of log10 CFU ml
21. The log10 CFU ml
21 is calculated
by log10(average number of colonies  dilution factor 
volume used to spread on LB agar plate). Three independent
experiments were performed in triplicate, one-way ANOVA
and Student’s t-tests were used to determine statistical
significance and the results were shown as the mean+ s.d.
2.5. Competitive mixed-treatment assay of rough small
colony variant isolates and PAO1
The evolved RSCVs and PAO1 cultures were prepared by
adjusting the optical density to OD600 ¼ 0.5 in ABTGC.
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PAO1 in ABTGC with and without 4 mM H2O2 (1 MIC).
The cultures were grown at 378C, 200 rpm. Twenty microlitre
samples were collected after a 4 h incubation. They were
diluted serially in 0.9% NaCl and 100 ml of cell culture was
cultivated on LB agar plates for 16 h at 378C. The RSCVs
and PAO1 were differentiated by the morphology of the colo-
nies. The number of colonies was counted for tabulation of
CFU ml21. The competition ratio was then calculated by
CFU ml21 of RSCV/CFU ml21 of PAO1. Three independent
experiments were performed in triplicate, one-way ANOVA
and Student’s t-tests were used to determine statistical
significance and the results were shown as the mean+ s.d.
2.6. DNA sequencing of rough small colony variants
isolates
Individual colonies of the ancestral PAO1, two random PAO1
isolates evolved in ABTGC only and 10 RSCV isolates were
first streaked on the LB agar plates and incubated at 378C
for 16 h. Single colonies were picked by a 1 ml inoculation
loop and grown in LB at 378C, 200 rpm for 16 h. Genomic
DNA of the P. aeruginosa strains was purified using
QIAamp DNA Mini Kit (Qiagen, Venlo, The Netherlands).
The quality control tests included NanoDrop (Thermo
Fisher Scientific) and Qubit (Thermo Fisher Scientific) to
ensure the concentration and quality of DNA, and DNA
electrophoresis (1% agar) to determine DNA integrity.
The genomicDNAwas then sequenced on an Illumina (San
Diego, CA, USA) MiSeq V3 platform, generating 300 bp long
paired-end reads using the method described in Chua et al.
[38]. The average insert sizes were 490–544 bp, and average
genomic coverage depths were 40–186 fold. Nucleotide differ-
ences were generated from the CLC GENOMICS WORKBENCH 8.0
(CLC bio, Aarhus, Denmark). Briefly, adapters and low quality
reads were trimmed. Paired-end reads in FASTQ format for
RSCV and control genomes were mapped against the P. aerugi-
nosa PAO1 genome (NC_002516). Both the mappings of RSCV
and control strains were compared with their ancestor PAO1,
and variants were detected using the quality based variant
detection method with the required frequency of 35%.
2.7. Measurement of mutation rates
PAO1 was grown in ABTGC with or without 2 mM H2O2
until stationary phase, and plated on LB agar plates with
and without 0.78 mg ml21 ciprofloxacin, using the method
described in Mandsberg et al. [39]. The mutated colonies cul-
tured on LB agar with ciprofloxacin were enumerated to
account for point mutations on the gyr gene that can easily
develop in P. aeruginosa exposed to ciprofloxacin [40]. The
mutation rate was then calculated by dividing the number
of mutations by the final CFU of cells grown on LB agar
plates without ciprofloxacin. Three independent experiments
were performed in triplicate, the Student’s t-test was used to
determine statistical significance and the results were shown
as the mean+ s.d.
2.8. The pcdrA-gfp reporter assay
The cultures of PAO1 with pcdrA-gfp reporter fusion were
grown in ABTGC with or without H2O2. In total, 200 ml ofcell culture was then transferred into each well of a 96-well
plate (triplicates). The OD600 and GFP fluorescence (excitation
485 nm/emission 535 nm) were measured using the Tecan
Infinite 200 microplate reader (Tecan, Austria). The relative
fluorescence intensity count was calculated by dividing
GFP values by OD600 values. Three independent experiments
were performed in triplicate, one-way ANOVA and Student’s
t-tests were used to determine statistical significance and the
results were shown as the mean+ s.d.
2.9. Quantification of pyoverdine
The cultures were grown in ABTGC with or without H2O2. In
total, 200 ml of cell culture was then transferred into each well
of a 96-well plate (triplicates). As previously described [13],
the OD600 and pyoverdine fluorescence (excitation 400 nm/
emission 460 nm) were measured using the Tecan microplate
reader, and the relative fluorescence intensity count calcu-
lated by dividing pyoverdine fluorescence values by OD600
values. Three independent experiments were performed in
triplicate, one-way ANOVA and Student’s t-tests were used
to determine statistical significance and the results were
shown as the mean+ s.d.
2.10. C-di-GMP quantification by liquid
chromatography–mass spectrometry
Fifteen millilitres of PAO1 cell culture treated with H2O2,
RSCVs, Burkholderia cenocepacia strains and Klebsiella pneumo-
niae strains were harvested and washed twice with 1 mM
ammonium acetate. An aliquot of cells was used for protein
quantification. The remaining cells were lysed in 1 ml aceto-
nitrile/methanol/ddH2O (v/v ratio 40 : 40 : 20) using a probe
tip ultrasonicator (amplitude 30%; 5 s on, 5 s off) for 1 min
on an ice slurry. The cell debris was removed by centrifuging
at 13 000g, 4 8C for 3 min, rinsing twice. The supernatant
containing the nucleotides was lyophilized with the vacuum
concentrator. The lyophilized nucleotides were resuspended
in 100 ml 1 mM ammonium acetate. The c-di-GMP standard
was also used as a reference to identify the c-di-GMP peak
and the concentration of c-di-GMP in the samples.
For the detection and quantification of c-di-GMP, a Thermo
Accela 1250 series LC system fitted with EQuanMax autosam-
pler and a Thermo Velos Pro Orbitrap mass spectrometer
(Thermo Fisher Scientific) were used. Chromatographic separ-
ation was achieved using a Nucleodur C18 Pyramid (2 mm 
50 mm, 3 mm) column (Macherey-Nagel GmbH, Du¨ren,
Germany) at 408C, with a solvent flow rate of 0.3 ml min21
and an injection volume of 10 ml. Buffer A was 10 mM
ammonium acetate buffer, containing 0.1% acetic acid, and
buffer B was acetonitrile, containing 0.1% acetic acid. Solvent
gradient conditions were as follows: 0% B from 0 to 3 min;
10% B at 3 min; 90% from 4th to 5th min; 0% B at 5.5th min
and equilibrated for 4.5 min. Total run time was 10 min.
Detection was carried out in positive ion electrospray ion-
ization (ESIþ) mode. The heater and capillary temperatures
were 3008C. Sheath, auxiliary and sweeper gas flows were
40, 15 and 1 arb. units, respectively. Source voltage was
3.5 kV. For quantitation, scan type in selected ion monitoring
mode was used at high-resolution (60 000), with an AGC
target of 1  106. Quantification was achieved via an MS/
MS experiment using collision induced dissociation (CID)
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isolation width of 1 Da and activation time of 30 ms.
To quantify protein concentration, a small aliquot of cell
culture was lysed in 100 ml 5 M sodium hydroxide at 958C
for 5 min. The protein concentration was then measured
using a Qubitw 2.0 fluorometer (Invitrogen, Thermo Fisher
Scientific, CA). The final concentration of c-di-GMP was
then normalized with protein quantity. Three independent
experiments were performed in triplicate, one-way ANOVA
and Student’s t-tests were used as to determine statistical
significance and results were shown as the mean+ s.d.
2.11. Psl staining by fluorescent concanavalin-A
Planktonic MiniTn7-gfp-tagged cells were grown in ABTGC þ
0, 0.5, 1 and 2 mM H2O2 at 378C, 200 rpm for 4 h. Addition-
ally, PAO1, mutants and evolved RSCVs with tagged
MiniTn7-gfp were grown until stationary phase in ABTGC
overnight at 378C, 200 rpm. Ten microlitres of cell culture
were then transferred to the glass slide and stained by 5 mM
concanavalin-A Alexa Fluorw 647 conjugate (Thermo Fisher
Scientific, Cat. No. C21421) [41].
Tomonitor fluorescence of GFP and Psl stain, the cells were
imaged using an LSM780 confocal laser scanning microscope
(CLSM; Carl Zeiss, Germany) with 40 objective or 63 oil
objective (for planktonic cells) and the images were processed
using IMARIS software (Bitplane AG, Zurich, Switzerland).
Three independent experiments were performed in triplicate
and representative images were shown.
2.12. Arabinose-inducible expression of Psl by PAO1/
pBAD-psl
A starting culture of PAO1/pBAD-psl cells containing an
L-arabinose-inducible promoter for psl operon expression was
grown inABTGCwith increasing concentrations of L-arabinose
at 378C, 200 rpm for 3 h until OD600 ¼ 0.3was established, as
described in Irie et al. [42]. The cultures were then treated with
and without 4 mM H2O2 and continued to be grown at 378C,
200 rpm for an additional 4 h. The cell culture was serially
diluted and plated on LB agar plates. The culture plates were
incubated at 378C for 16 h. The colonies were counted for tabu-
lation of CFU ml21. Three independent experiments were
performed in triplicate, one-way ANOVA and Student’s
t-tests were used as statistical tests and the results were
shown as the mean+ s.d.
2.13. Biofilm quantification of PAO1/pBAD-psl by crystal
violet assay
The PAO1/pBAD-psl biofilms were grown in 1 ml ABTGCwith
increasing concentrations of L-arabinose at 378C in 24-well
plates (Nunc, Denmark). The biofilms were washed three
times with 0.9% NaCl and stained with 0.1% crystal violet
for 15 min. Excess crystal violet was washed off with 0.9%
NaCl. The stained biofilms were dissoluted by 100% ethanol
and their OD595 values were quantified using a Tecan Infinite
200 microplate reader (Tecan, Austria). Three independent
experiments were performed in triplicate, one-way ANOVA
and Student’s t-tests were used to determine statistical
significance and the results were shown as the mean+ s.d.2.14. Cellulase treatment of Pseudomonas aeruginosa
cultures to degrade Psl
The P. aeruginosa cultures were grown overnight and pre-
pared by adjusting the optical density to OD600 ¼ 0.1 in
ABTGC with 1 mg ml21 cellulase (Sigma-Aldrich, Cat. No.
C9748) [42]. The cultures were grown to OD600 ¼ 0.3 at
378C, 200 rpm for 3 h. The cultures were treated with 0 or
4 mM H2O2 and further grown at 378C, 200 rpm for 4 h.
The cell culture was serially diluted and plated on LB agar
plates. The culture plates were incubated in 378C for 16 h.
Colonies were counted for tabulation of CFU ml21. Three
independent experiments were performed in triplicate. One-
way ANOVA and Student’s t-tests were used to determine
statistical significance and the results were shown as the
mean+ s.d.
2.15. RAW264.7 macrophages culture
ThemurineRAW264.7macrophage cell lines (ATCCNo.TIB-71)
were cultivated in Dulbecco’s modified Eagle’s medium
(DMEM) (Life Technologies, Thermo Fisher Scientific), supple-
mented with 10% fetal bovine serum (FBS) (GibcoTM, Thermo
Fisher Scientific). Cell cultures were incubated in 75 cm2 cell
culture flasks at a density of 1.0 106 cellsml21 at 378C, 5%
CO2 for 72 h.
2.16. Macrophage phagocytosis assay
As previously described [12], 5  105 macrophages were
grown in each well of a 24-well culture plate (Nunc, Den-
mark). Macrophages were infected with bacterial
suspension at a multiplicity of infection (MOI) of 100 : 1.
The co-cultures were incubated at 378C and 5% CO2 for 2 h.
The macrophages were washed three times with phosphate-
buffered saline (PBS) to remove extracellular bacteria, and
then lysed with ddH2O containing 0.5% Triton X-100. The
cell lysates were then serially diluted, and 100ml of each
dilution was plated on triplicate LB agar plates and incubated
overnight at 378C. The number of colonies was enumerated,
and CFUml21 was tabulated. Experiments were performed
in triplicate, one-way ANOVA and Student’s t-tests were
used to determine statistical significance and the results
were shown as the mean+ s.d.
2.17. Macrophage cytotoxicity assay
RAW264.7 macrophages (5 105ml21 in each well) were
grown in 24-well culture plates as previously described [12].
Triplicate cultures were infected with bacterial suspension
at a MOI of 100 : 1. Macrophages were incubated for 4 h
in 378C, 5% CO2, then 20mM propidium iodide (PI) was
used to stain dead cells and assess macrophage cytotoxicity,
leaving live cells unstained. Macrophages stained by PI
(excitation 535 nm, emission 617 nm) under epifluorescent
microscopy (20 objective) were counted as dead. Macropha-
ges from five replicate images (on average 100 macrophages
per image) of each sample were counted, enabling the ratio of
dead cells to live cells to be calculated. Three independent
experiments were performed in triplicate, one-way ANOVA
and Student’s t-tests were used to establish statistical
significance and the results were shown as the mean+ s.d.
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Figure 1. Evolution assay of Pseudomonas aeruginosa in H2O2. (a) Percentage of rough small colony variants (RSCVs) after evolution in the presence of H2O2
compared with the control. (b) Resistance of RSCV isolates compared with PAO1 in H2O2. (c) Competitive fitness assay between RSCV isolates and PAO1 grown
in H2O2. (d ) Antioxidants (glutathione; GSH) reduced the proportion of RSCVs formed with ROS treatment, in a dose-dependent manner. Means+ s.d. from
triplicate experiments are shown.
Table 1. MIC of evolved RSCV isolates to H2O2.
strain/isolate MIC (mM)
PAO1 4
RSCV 1 32
RSCV 2 64
RSCV 3 64
RSCV 4 64
RSCV 5 64
RSCV 6 32
RSCV 7 64
RSCV 8 64
RSCV 9 8
RSCV 10 64
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3.1. Emergence of rough small colony variants during
adaptive evolution of Pseudomonas aeruginosa
against ROS
To determine if oxidative stress provokes the adaptive evol-
ution of P. aeruginosa, P. aeruginosa was cultivated in the
presence of a sub-lethal concentration of H2O2 (2 mM, 0.5 
minimal inhibitory concentration (MIC)) for 120 generations.
This simulated the presence of ROS produced by polymorpho-
nuclear leucocytes (PMNs) in the CF lung, which generate
oxidative stress as a selective pressure on P. aeruginosa cells
[43]. Although a millimolar range of H2O2 is required to kill
most bacteria and bacteria internalized in the phagosome are
usually exposed to micromolar concentrations, the rates of
free radical generation within the phagosome are estimated
to be 10 000 times faster, leading to higher concentrations of
ROS than have been experimentally tested [44]. Hence, the
sufficiently high levels of ROS present can be potentially
damaging to bacterial cells.
After 120 generations, colonies with RSCV phenotypewere
observed on the agar plates inoculated with 2 mMH2O2 treat-
ment (electronic supplementary material, figure S1), while no
distinctive phenotypes were observed in the control popu-
lations without H2O2 treatment. The percentage of RSCVs in
H2O2 exposed P. aeruginosa populations reached around 40%
(figure 1a), implying that ROS could significantly contribute
to the occurrence of RSCVs. We also showed that
P. aeruginosa was able to evolve within 120 generations, when
compared with a shorter 47.5 generation period in the
evolution of RSCVs with antibiotics [18]. As P. aeruginosa canpersist in CF lungs for decades, spanning 200 000 bacterial gen-
erations [33,45], there is more than sufficient time for the
metabolically active [46] P. aeruginosa to adapt in CF lungs.
The resistance of randomly selected RSCV clones to H2O2
was then measured. The RSCVs showed up to 16-fold increase
in MIC to H2O2 (table 1) compared with the ancestral PAO1
strain. The RSCV clones also survived better than PAO1 after
treatment with 4 mM H2O2 (1 MIC) (figure 1b). Next, we
measured the fitness of the selected RSCVs by co-culturing
them with ancestral PAO1. In the absence of 2 mM H2O2, the
ancestral PAO1 outcompeted the RSCVs (figure 1c), but
RSCVs outcompeted PAO1 in the presence of 2 mM H2O2
(figure 1d), confirming that the RSCVs were favoured and
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RSCV isolates ‘7’ and ‘8’ showed only slightly higher fit-
ness against the PAO1 ancestral strain, compared with the
rest of the RSCV isolates, implying different magnitudes of
adaptation within the evolved populations.
We determined if the selection of RSCV by oxidative
stress could be neutralized by the addition of L-glutathione,
a commonly used antioxidant [47]. As expected, L-gluta-
thione reduced the proportion of RSCVs formed in a
dose-dependent manner, compared with that in the absence
of antioxidants (figure 1d ).3.2. Increased c-di-GMP content confers resistance
of rough small colony variants to H2O2
As c-di-GMP signalling is implicated in RSCV formation [27],
we examined the intracellular c-di-GMP content in the selected
RSCV isolates. Liquid chromatography–mass spectrometry
(LC-MS) quantification of the whole cell extract showed that
the RSCV isolates contained higher intracellular c-di-GMP
than wild-type P. aeruginosa PAO1 (figure 2a). This was
in accordance with their higher expression levels of the
c-di-GMP reporter fusion pcdrA-gfp [48,49] (figure 2b) and
higher pyoverdine production [50,51] (figure 2c), compared
with that of ancestral PAO1. To confirm that the increased
H2O2 resistance of RSCVs was attributed to enhanced
intracellular c-di-GMPcontent,we transformed a plac-yhjHplas-
mid [52] into the RSCVs to deplete their intracellular c-di-GMP.
As expected, constitutive expression of the YhjH PDE in the
RSCVs attenuated their resistance to H2O2 (figure 2d). These
results indicate that c-di-GMP signalling plays an important
role in the evolutionary development of PAO1 to RSCVs
under ROS stress and corroborated previous studies showing
that CF RSCV isolates possessed high c-di-GMP levels [27].3.3. Comparative genomic analysis of rough small
colony variants reveal parallel evolution traits
To gain insights into the underlying genetic changes contri-
buting to c-di-GMP-linked RSCV phenotype development
with prolonged oxidative stress via c-di-GMP signalling, we
sequenced the genomes of 10 randomly selected RSCV iso-
lates and 2 control PAO1 colonies using the Illumina MiSeq
platform. Two random control PAO1 colonies were picked
from cultures grown in a medium without H2O2 for 120 gen-
erations. A series of point mutations were evident in the
sequences of 10 randomly selected RSCVs and control
PAO1 colonies, compared with the ancestor PAO1 sequence
(electronic supplementary material, tables S2 and S3). The
distribution of the identified mutations across the PAO1
genome is illustrated in figure 3a. The functional annotation
of these RSCV-associated mutations is listed in the electronic
supplementary material, tables S2 and S3. Several parallel
evolution traits were observed from both RSCVs and control
PAO1 colonies, including mutations in PA0727 and PA0720
(encoding phage-related genes), PA1458 (encoding a two
component sensor), exsC (encoding an anti-anti-activator of
the type III secretion system), PA2877 (encoding a probable
transcriptional regulator), intergenic region 4 699 910 bp and
intergenic region 5 242 141 bp.
As P. aeruginosa commonly accumulate mutations even in
planktonic cultures and the mutations are common between
control and ROS-evolved strains, the above-mentioned
mutations are not deemed to be generated by ROS pressure.
We also found that the mutations were not attributed to
highly mutagenic growth conditions, as there was no signifi-
cant increase in mutation rates with ROS treatment
(electronic supplementary material, figure S2) compared with
control medium, with the mutation rates similar to previous
reports [38]. Moreover, the cell populations did not develop
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Figure 3. Genetic sequencing for identification of mutation sites. (a) Number of mutations identified in evolved genotypes. (b) Location of mutations in the wspF
gene of different RSCVs.
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repair and its mutation can lead to the emergence of multiple
phenotypic variants [53].
Interestingly, there was one parallel evolution trait, wspF
gene mutation, which could only be detected in the genomes
from the RSCVs and not in the control PAO1 colonies. All
RSCV genomes had loss of function mutations in the wspF
gene at different sites (figure 3b; electronic supplementary
material, table S1). The DwspF mutation caused the
de-repression of the WspR DGC, leading to increased
c-di-GMP synthesis and high intracellular c-di-GMP content,
resulting in bacterial cell clumping (electronic supplementary
material, figure S1) [54]. This indicated that enhanced intra-
cellular c-di-GMP content might play a positive role in
P. aeruginosa’s adaptation to oxidative stress.
3.4. Regulatory roles of wspF on ROS-mediated
resistance of Pseudomonas aeruginosa
To investigate whether intracellular c-di-GMP content is
increased under conditions of ROS stress, we measured the
intracellular c-di-GMP content and expression of c-di-GMP
reporter fusion pcdrA-gfp with H2O2 treatment. Both intracellu-
lar c-di-GMP content and pcdrA-gfp expression levels were
increased in PAO1 strain after exposure to 4 mM H2O2 for 4 h
(figure 4a,b). Given the increase in intracellular c-di-GMP con-
tent in adaptation to H2O2 stress and the presence of wspF
mutations in our experimental evolution assay, we hypoth-
esized that the genetic basis of adaptation to ROS was
directly linked to the mutation in wspF, which resulted in the
de-repression of wspR DGC [8] and a subsequent increased
production of c-di-GMP. Hence, we used an isogenic DwspF
mutant as previously described [51] to ascertain ROS resistance.
We also used ‘locked’ high and low c-di-GMP content strains of
PAO1 by using the plac-yedQ and plac-yhjH plasmids, respect-
ively. The yedQ gene encodes an E. coli DGC that synthesizesc-di-GMP [50,55,56], thus the exogenous addition of the plac-
yedQ would enable the constitutive production of c-di-GMP
within the species, resulting in the highly aggregative nature
of the colonies (electronic supplementary material, figure S1).
The yhjH gene encodes an E. coli PDE that degrades c-di-
GMP [56,57], so the presence of plac-yhjH plasmid would
cause the reduction of intracellular c-di-GMP levels.
The DwspF and PAO1/plac-yedQmutants were more resist-
ant to 4 mMH2O2 (1MIC) than PAO1,while PAO1/plac-yhjH
was more sensitive to 4 mM H2O2 than PAO1 (figures 4c and
5a). Epistatic mutations of wspR gene restored pcdrA-gfp
expression (figure 4d ) to that of the wild-type of a few selected
RSCV isolates. This also caused the RSCV isolates to lose their
resistance to H2O2 (figure 4e), confirming that PAO1 could
adapt to ROS stress simply via the mutagenesis of wspF.
As clinical RSCV isolates with wspF mutations were iso-
lated from CF patients [27], we also tested the ROS resistance
of clinical RSCV isolates with known wspF mutations (CF173-
2005 isolate of lineage H and a related isolate CF273-2002)
[45]. Such RSCV isolates from the CF lungs possess higher
c-di-GMP levels [8]. We showed that they were resistant to
4 mMH2O2 and the insertion of the plac-yhjH plasmid reduced
their resistance to ROS (figure 4f). This confirmed that
the clinical RSCV isolates were adapted to the presence of
ROS in the human body and cemented the involvement of
c-di-GMP regulation in biofilm ROS resistance.3.5. C-di-GMP-dependent exopolysaccharides are
required for Pseudomonas aeruginosa ROS
resistance
To understand how the wsp operon mediates ROS resistance,
we tested whether exopolysaccharides could interfere with
the action of ROS on P. aeruginosa, as thewsp operon regulates
the expression of Pel and Psl exopolysaccharide synthetic
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Figure 5. C-di-GMP-mediated exopolysaccharides were required for resistance to ROS stress. (a) Resistance of PAO1, DwspFDpelADpslBCD and DpelADpslBCD/
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DpelADpslBCD/plac-yedQ mutants, which could not produce
Pel and Psl exopolysaccharides, were highly sensitive to
H2O2, even though they contain high intracellular c-di-GMP
levels (figure 5a). To identify which of the two exopolysac-
charides were more important in conferring ROS resistance,
we further showed that the DpslBCD/plac-yedQwas more sen-
sitive to ROS than DpelA/plac-yedQ, thus providing the first
indication that Psl is more important than Pel in conferring
ROS resistance (figure 5b). We then stained the Psl using afluorescent lectin and observed the formation of small
aggregates and enhanced production of Psl in PAO1 with
0.5, 1 and 2mM H2O2 treatment (figure 5c). Moreover, the
evolved RSCVs, DwspF and PAO1/plac-yedQ mutants pro-
duced higher amounts of Psl than PAO1, as indicated by
the fluorescence intensity of the Psl stain (figure 5d).
We further validated the requirement of Psl for ROS resist-
ance by using a PAO1/pBAD-pslmutant by replacing its native
psl operon promoter with an L-arabinose-inducible promoter
[58]. Upon addition of L-arabinose, there was an increase in
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PAO1/pBAD-psl to ROS improved with increasing L-arabinose
concentrations (figure 5f), indicating that Psl production is
positively correlated with ROS resistance. Treatment with cel-
lulase, which degrades Psl [58], rendered the PAO1/pBAD-psl
sensitive to ROS treatment (figure 5g). Hence, Psl plays a
major role in P. aeruginosa ROS resistance. Moreover, Psl acts
as a signal for biofilm formation [43], thus could possibly pro-
vide positive feedback for biofilm formation and the
emergence of RSCVs upon ROS exposure.3.6. C-di-GMP signalling confers resistance
to macrophage phagocytosis
ROS aremostly produced by host leucocytes, such as PMNs and
macrophages, to kill the invading pathogens, which in turn
induce c-di-GMP content to confer ROS resistance. Because the
evolved RSCVs and the DwspFmutant showed increased resist-
ance toH2O2 in vitro, we examinedwhether c-di-GMP signalling
could protect P. aeruginosa from phagocytosis by RAW264.7
macrophages. Here, the DwspF mutant and evolved RSCVs
were more efficient in evading phagocytosis by macrophages
than PAO1 (figure 6a,b). Although the PAO1/plac-yhjH strain
was subjected to lower phagocytosis levels by the macrophages
thanDwspFmutant (figure 6b), we found that it was highly cyto-
toxic to macrophages compared with PAO1 and the DwspF
mutant (figure 6c). Hence, the lower macrophage phagocytosis
level could be attributed to increased macrophage killing by
PAO1/plac-yhjH. Moreover, the PAO1/plac-yhjH was exposed
to higher ROS production from macrophages than PAO1 and
the DwspF mutant (figure 6d).
Further, Psl played a role in evadingphagocytosis bymacro-
phages, as DpslBCD/plac-yedQ was internalized at a higherrate than PAO1/plac-yedQ and DpelA/plac-yedQ (figure 6e).
However, Psl was not involved in the cytotoxicity against
macrophages, as Psl was not a virulence factor and there were
no significant differences between PAO1/plac-yedQ and
DpslBCD/plac-yedQ in killing the macrophage cells (figure 6f).
Nonetheless, increases in c-di-GMP levels by plac-yedQ plasmid
insertion reduced the cytotoxicity to macrophages, which
corroborated the DwspF mutant results (figure 6f).4. Discussion
Resistance to oxidative stress is essential for pathogens to
survive in the host environment. Here, we employed the
adaptive experimental evolution assay to investigate P. aeru-
ginosa’s ROS resistance via the emergence of RSCVs with
enhanced biofilm forming capacity (figure 7). The production
of superoxide in the phagosome was estimated at 1–4 M
[59,60], implying that the use of a millimolar range of H2O2
to induce pathogen evolution in our study was relevant to
the host environment. We observed an adaptive evolution
trait of mutagenesis in the wspF gene, resulting in c-di-GMP
signal induction. Our findings are clinically significant as
RSCVs with wspF mutations are frequently isolated from
CF patients and these showed similar resistance to oxidative
stress as our evolved RSCVs.
The regulatory role of c-di-GMP signalling on oxidative
stress response is extendable to other pathogenic species,
including Burkholderia cenocepacia and Klebsiella pneumoniae
(electronic supplementary material, figure S3).The ROS-
induced evolution of RSCVs could potentially explain the
emergence of RSCVs by B. cenocepacia and K. pneumoniae
during infections [61,62]. The induction of c-di-GMP signall-
ing has been linked to increased production of Psl
repeated
exposure to
oxidative stress
wild-type cell evolved RSCV cell
macrophage
limited exposure
to oxidative stress
adaptive
evolution
mutation of wspF gene
induction of c-di-GMP signalling
increased Psl production
limited exposure
to phagocytosis
Psl
Figure 7. Model of Pseudomonas aeruginosa adaptation to oxidative stress. Upon repeated exposure of oxidative stress, the cells evolved to form RSCVs via wspF
mutation, resulting in the induction of c-di-GMP signalling and increased Psl production. This endowed RSCVs with the ability to resist oxidative stress and
phagocytes.
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biofilm structure, act as signal for biofilm formation and
offers protection against antibiotics [43,63], the role of Psl as a
barrier in the biofilm possibly reduces ROS penetration across
bacterial membranes and causes cell damage. This confers bac-
terial cells with a biofilm-based protective mechanism from
host immune cell generated ROS and/or antimicrobials.
As the oxidative stress resistance mechanism is commonly
utilized by various pathogens, we propose the following
strategies to modulate c-di-GMP signalling and treat
biofilm-associated infections: (i) employing matrix-degrading
enzymes, such as cellulase or the PslG hydrolase [64] to
degrade Psl-like polysaccharides followed by effective killing
of biofilm cells byantibiotics; and (ii) administering antioxidant
drugs during early infection stages to prevent pathogen adap-
tation. To nullify P. aeruginosa’s oxidative stress adaptation in
our evolution assays, we used the antioxidant L-glutathione,
which reduced the emergence of RSCVs. This also indirectly
reduced the resistance ofP. aeruginosa to host immune clearance
strategies such as phagocytosis. Given the lower levels of gluta-
thione and increased oxidative stress from neutrophils in CF
patients’ lungs, antioxidant therapy could potentially prove
effective against inflammation [65,66].
In summary, the interactions between the immune system
and pathogens are highly complex, driving the pathogen to
adapt accordingly to different host immune system stimuli.Pseudomonas aeruginosa appears to draw a complex yet fine
balance between its numerous DGCs and PDEs, thus leading
to phenotypic variation, and ensuring the survival of its
species. Hence, chemical manipulation of the c-di-GMP
signalling pathway represents a promising strategy to
manage chronic bacterial infections.Data accessibility. TheWhole Genome Shotgun bioproject for P. aeruginosa
adaptation to ROS has been deposited at in the NCBI Short Read
Archive (SRA) database with accession code SRP062804.
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